Carboxamide compound

Abstract

The present invention provides: a compound having LPA receptor antagonist activity; and a pharmaceutical composition containing the compound. Specifically, the present invention provides: a compound represented by the general formula (I) [where the symbols have the meanings set forth in the description] or a deuterated product thereof or a pharmaceutically acceptable salt of the compound or the deuterated product; and a pharmaceutical composition containing the compound, the deuterated product, or the pharmaceutically acceptable salt.